Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azathioprine for early Parkinson's disease progression
ISRCTN14616801Phase 2Completed
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Mar 2021
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in Parkinson's disease (PD) comparing Azathioprine with Placebo (2 arms). Primary endpoint: Primary: axial and gait symptoms at 12 months. Started Mar 2021; status: completed.
02
Drugs
azathioprine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on ISRCTN14616801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN14616801.